Page 94 - Read Online

Skorupan et al. J Cancer Metastasis Treat 2023;9:5 https://dx.doi.org/10.20517/2394-4722.2022.106 Page 23 of 26

85. Toshima F, Inoue D, Yoshida K, et al. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with
pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol 2016;41:508-20. DOI PubMed
86. Feng YF, Chen JY, Chen HY, et al. 110 patients with adenosquamous carcinomas of the pancreas (PASC): imaging differentiation of
small (≤ 3 cm) versus large (> 3 cm) tumors. Abdom Radiol 2019;44:2466-73. DOI PubMed
87. Zhao R, Jia Z, Chen X, et al. CT and MR imaging features of pancreatic adenosquamous carcinoma and their correlation with
prognosis. Abdom Radiol 2019;44:2822-34. DOI PubMed
88. Schawkat K, Tsai LL, Jaramillo-Cardoso A, et al. Use of ring-enhancement and focal necrosis to differentiate pancreatic
adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI. Clin Imaging 2021;73:134-8. DOI PubMed
89. Ren S, Zhao R, Cui W, et al. Computed tomography-based radiomics signature for the preoperative differentiation of pancreatic
adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Front Oncol 2020;10:1618. DOI PubMed PMC
90. Arco H, Chakiba-Brugère C, Salabert L, Béchade D. Adenosquamous carcinoma of the pancreas. Clin Med Insights Oncol
2019;13:1179554919886587. DOI PubMed PMC
91. Inomata N, Masuda A, Itani T, et al. An autopsy case of granulocyte colony-stimulating factor-producing pancreatic adenosquamous
carcinoma. Clin J Gastroenterol 2020;13:448-54. DOI PubMed
92. Skafida E, Grammatoglou X, Glava C, et al. Adenosquamous carcinoma of the pancreas: a case report. Cases J 2010;3:41. DOI
93. Na YJ, Shim KN, Cho MS, et al. Primary adenosquamous cell carcinoma of the pancreas: a case report with a review of the Korean
literature. Korean J Intern Med 2011;26:348-51. DOI PubMed PMC
94. Kelly K, Moore C. Two rare cases of pancreatic adenosquamous carcinoma: a review of the literature with focus on radiologic
findings. Radiol Case Rep 2019;14:809-13. DOI PubMed PMC
95. Nabae T, Yamaguchi K, Takahata S, et al. Adenosquamous carcinoma of the pancreas: report of two cases. Am J Gastroenterol
1998;93:1167-70. DOI
96. Kurdi YM, Peck JR, Roth R, Conwell DL. A case of pancreatic adenosquamous carcinoma obstructing the common bile and
pancreatic ducts, duodenum, and gastric outlet. Pancreas 2016;45:e9-e10. DOI PubMed
97. López-Tomassetti-Fernández EM, Favre-Rizzo J, Delgado-Plasencia L, Hernández-Hernández JR. Hypercalcemia associated with
adenosquamous pancreatic carcinoma: a reason to initiate palliative treatment. Rev Esp Enferm Dig 2013;105:425-8. DOI PubMed
98. Kobayashi N, Higurashi T, Iida H, et al. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of
malignancy (HHM). J Hepatobiliary Pancreat Surg 2008;15:531-5. DOI PubMed
99. Inoue T, Nagao S, Tajima H, et al. Adenosquamous pancreatic cancer producing parathyroid hormone-related protein. J
Gastroenterol 2004;39:176-80. DOI PubMed
100. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-9. DOI PubMed
101. Wild AT, Dholakia AS, Fan KY, et al. Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous
carcinoma of the pancreas. J Gastrointest Oncol 2015;6:115-25. DOI PubMed PMC
102. Hue JJ, Katayama E, Sugumar K, et al. The importance of multimodal therapy in the management of nonmetastatic adenosquamous
carcinoma of the pancreas: analysis of treatment sequence and strategy. Surgery 2021;169:1102-9. DOI PubMed
103. Altman AM, Wirth K, Marmor S, et al. Completion of adjuvant chemotherapy after upfront surgical resection for pancreatic cancer is
uncommon yet associated with improved survival. Ann Surg Oncol 2019;26:4108-16. DOI PubMed
104. DePeralta DK, Ogami T, Zhou JM, et al. Completion of adjuvant therapy in patients with resected pancreatic cancer. HPB
2020;22:241-8. DOI PubMed PMC
105. Romano E, Janati S, Monnier L, et al. Outcomes of vaginal squamous cell carcinoma of patients treated with radiation therapy: a
series of 37 patients from a single expert center. Clin Transl Oncol 2020;22:1345-54. DOI PubMed
106. Maubec E. Update of the management of cutaneous squamous-cell carcinoma. Acta Derm Venereol 2020;100:adv00143. DOI
PubMed PMC
107. Mendenhall WM, Strojan P, Lee AWM, et al. Radiotherapy in the management of glottic squamous cell carcinoma. Head Neck
2020;42:3558-67. DOI PubMed
108. Lin HN, Chen LQ, Shang QX, Yuan Y, Yang YS. A meta-analysis on surgery with or without postoperative radiotherapy to treat
squamous cell esophageal carcinoma. Int J Surg 2020;80:184-91. DOI
109. Yamaue H, Tanimura H, Onishi H, et al. Adenosquamous carcinoma of the pancreas: successful treatment with extended radical
surgery, intraoperative radiation therapy, and locoregional chemotherapy. Int J Pancreatol 2001;29:53-8. DOI
110. Hsu JT, Yeh CN, Chen YR, et al. Adenosquamous carcinoma of the pancreas. Digestion 2005;72:104-8. DOI
111. Brunetti O, Aprile G, Marchetti P, et al. Systemic chemotherapy for advanced rare pancreatic histotype tumors: a retrospective
multicenter analysis. Pancreas 2018;47:759-71. DOI PubMed
112. Tanaka N, Ohoida J, Matuno T, et al. Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis
factor-alpha and 5-fluorouracil combined treatment. Anticancer Res 1994;14:2739-42. PubMed
113. Noel P, Hussein S, Ng S, et al. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated
fibroblasts. Oncogenesis 2020;9:100. DOI PubMed PMC
114. Skorupan N, Ahmad MI, Steinberg SM, et al. A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory
adenosquamous carcinoma of the pancreas. Future Oncol 2022;18:2475-81. DOI PubMed PMC
115. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg
Pathol 1992;16:815-37. DOI PubMed